Implantable Cardiovascular Devices Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Implantable Cardiovascular Devices, Including Pacemakers, Implantable Cardioverter-defibrillators, Ventricular Assist Devices and Cardiac Loop Recorders, Are Designed to Help Manage a Person's Heart Rate or Rhythm Problems and to Control or Monitor Irregular Heartbeats in People with Certain Arrhythmias and Heart Failure, for Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias. It is Used in Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias.Implantable Cardiovascular Devices Can Help Support Cardiac Patients by Using Painless Electrical Signals to Keep the Heart Beating Regularly and Improve Function when the Device is Placed Through a Minimally Invasive Procedure. in Addition to Delivering Electrical Pulses, the Implantable Device is Now Able to Send Clinical Data Directly to the Physician Using Remote Monitoring. It Will Continuously Collect Information About the Heart Rhythm, Which is Transmitted Wirelessly to Medical Personnel when Symptoms Occur, Thus Facilitating Remote Monitoring, Which Doctors Can Use to Manage the Condition and Potentially Detect Signs of Deterioration Earlier. Not Only Do These Devices Improve Heart Disease Symptoms, but They Have Been Shown to Improve Long-term Survival Rates.These Devices Continue to Get Smaller, More Efficient, and Have Longer Battery Life. These Devices Are Usually Inserted Under Local Anesthesia and They Are Located Just Below the Collarbone to Avoid Being Visible from the Outside of the Body. Most Devices Require Periodic Monitoring, Usually Once a Year, on an Outpatient Basis.
This report aims to provide a comprehensive presentation of the global market for Implantable Cardiovascular Devices study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Implantable Cardiovascular Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Cardiovascular Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Implantable Cardiovascular Devices companies in 2021 (%)
The global Implantable Cardiovascular Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Cardioverter Defibrillators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Cardiovascular Devices include Medtronic, Abbott, Boston Scientific, AbioMed, Philips Healthcare, Biotronik Se, Angel Medical Systems, Berlin Heart and LivaNova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Implantable Cardiovascular Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Implantable Cardiovascular Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Type, 2021 (%)
Implantable Cardioverter Defibrillators
Implantable Pacemakers
Insertable Loop Recorders
Ventricular Assist Devices
Global Implantable Cardiovascular Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialized Hospital
Others
Global Implantable Cardiovascular Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Cardiovascular Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Cardiovascular Devices revenues share in global market, 2021 (%)
Key companies Implantable Cardiovascular Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Implantable Cardiovascular Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
AbioMed
Philips Healthcare
Biotronik Se
Angel Medical Systems
Berlin Heart
LivaNova
Shree Pacetronix
Jarvik Heart
EBR Systems
Medico SpA
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Implantable Cardiovascular Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Cardiovascular Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Cardiovascular Devices Overall Market Size
2.1 Global Implantable Cardiovascular Devices Market Size: 2021 VS 2028
2.2 Global Implantable Cardiovascular Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Implantable Cardiovascular Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Implantable Cardiovascular Devices Players in Global Market
3.2 Top Global Implantable Cardiovascular Devices Companies Ranked by Revenue
3.3 Global Implantable Cardiovascular Devices Revenue by Companies
3.4 Global Implantable Cardiovascular Devices Sales by Companies
3.5 Global Implantable Cardiovascular Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Implantable Cardiovascular Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Implantable Cardiovascular Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Cardiovascular Devices Players in Global Market
3.8.1 List of Global Tier 1 Implantable Cardiovascular Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Cardiovascular Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Implantable Cardiovascular Devices Market Size Markets, 2021 & 2028
4.1.2 Implantable Cardioverter Defibrillators
4.1.3 Implantable Pacemakers
4.1.4 Insertable Loop Recorders
4.1.5 Ventricular Assist Devices
4.2 By Type - Global Implantable Cardiovascular Devices Revenue & Forecasts
4.2.1 By Type - Global Implantable Cardiovascular Devices Revenue, 2017-2022
4.2.2 By Type - Global Implantable Cardiovascular Devices Revenue, 2023-2028
4.2.3 By Type - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Implantable Cardiovascular Devices Sales & Forecasts
4.3.1 By Type - Global Implantable Cardiovascular Devices Sales, 2017-2022
4.3.2 By Type - Global Implantable Cardiovascular Devices Sales, 2023-2028
4.3.3 By Type - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
4.4 By Type - Global Implantable Cardiovascular Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Implantable Cardiovascular Devices Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Specialized Hospital
5.1.4 Others
5.2 By Application - Global Implantable Cardiovascular Devices Revenue & Forecasts
5.2.1 By Application - Global Implantable Cardiovascular Devices Revenue, 2017-2022
5.2.2 By Application - Global Implantable Cardiovascular Devices Revenue, 2023-2028
5.2.3 By Application - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Implantable Cardiovascular Devices Sales & Forecasts
5.3.1 By Application - Global Implantable Cardiovascular Devices Sales, 2017-2022
5.3.2 By Application - Global Implantable Cardiovascular Devices Sales, 2023-2028
5.3.3 By Application - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
5.4 By Application - Global Implantable Cardiovascular Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Implantable Cardiovascular Devices Market Size, 2021 & 2028
6.2 By Region - Global Implantable Cardiovascular Devices Revenue & Forecasts
6.2.1 By Region - Global Implantable Cardiovascular Devices Revenue, 2017-2022
6.2.2 By Region - Global Implantable Cardiovascular Devices Revenue, 2023-2028
6.2.3 By Region - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Implantable Cardiovascular Devices Sales & Forecasts
6.3.1 By Region - Global Implantable Cardiovascular Devices Sales, 2017-2022
6.3.2 By Region - Global Implantable Cardiovascular Devices Sales, 2023-2028
6.3.3 By Region - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Implantable Cardiovascular Devices Revenue, 2017-2028
6.4.2 By Country - North America Implantable Cardiovascular Devices Sales, 2017-2028
6.4.3 US Implantable Cardiovascular Devices Market Size, 2017-2028
6.4.4 Canada Implantable Cardiovascular Devices Market Size, 2017-2028
6.4.5 Mexico Implantable Cardiovascular Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Implantable Cardiovascular Devices Revenue, 2017-2028
6.5.2 By Country - Europe Implantable Cardiovascular Devices Sales, 2017-2028
6.5.3 Germany Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.4 France Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.5 U.K. Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.6 Italy Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.7 Russia Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.8 Nordic Countries Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.9 Benelux Implantable Cardiovascular Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Implantable Cardiovascular Devices Revenue, 2017-2028
6.6.2 By Region - Asia Implantable Cardiovascular Devices Sales, 2017-2028
6.6.3 China Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.4 Japan Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.5 South Korea Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.6 Southeast Asia Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.7 India Implantable Cardiovascular Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Implantable Cardiovascular Devices Revenue, 2017-2028
6.7.2 By Country - South America Implantable Cardiovascular Devices Sales, 2017-2028
6.7.3 Brazil Implantable Cardiovascular Devices Market Size, 2017-2028
6.7.4 Argentina Implantable Cardiovascular Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Implantable Cardiovascular Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Implantable Cardiovascular Devices Sales, 2017-2028
6.8.3 Turkey Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.4 Israel Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.6 UAE Implantable Cardiovascular Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Corporate Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Cardiovascular Devices Major Product Offerings
7.1.4 Medtronic Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.1.5 Medtronic Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Cardiovascular Devices Major Product Offerings
7.2.4 Abbott Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Key News
7.3 Boston Scientific
7.3.1 Boston Scientific Corporate Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Implantable Cardiovascular Devices Major Product Offerings
7.3.4 Boston Scientific Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.3.5 Boston Scientific Key News
7.4 AbioMed
7.4.1 AbioMed Corporate Summary
7.4.2 AbioMed Business Overview
7.4.3 AbioMed Implantable Cardiovascular Devices Major Product Offerings
7.4.4 AbioMed Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.4.5 AbioMed Key News
7.5 Philips Healthcare
7.5.1 Philips Healthcare Corporate Summary
7.5.2 Philips Healthcare Business Overview
7.5.3 Philips Healthcare Implantable Cardiovascular Devices Major Product Offerings
7.5.4 Philips Healthcare Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.5.5 Philips Healthcare Key News
7.6 Biotronik Se
7.6.1 Biotronik Se Corporate Summary
7.6.2 Biotronik Se Business Overview
7.6.3 Biotronik Se Implantable Cardiovascular Devices Major Product Offerings
7.6.4 Biotronik Se Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.6.5 Biotronik Se Key News
7.7 Angel Medical Systems
7.7.1 Angel Medical Systems Corporate Summary
7.7.2 Angel Medical Systems Business Overview
7.7.3 Angel Medical Systems Implantable Cardiovascular Devices Major Product Offerings
7.7.4 Angel Medical Systems Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.7.5 Angel Medical Systems Key News
7.8 Berlin Heart
7.8.1 Berlin Heart Corporate Summary
7.8.2 Berlin Heart Business Overview
7.8.3 Berlin Heart Implantable Cardiovascular Devices Major Product Offerings
7.8.4 Berlin Heart Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.8.5 Berlin Heart Key News
7.9 LivaNova
7.9.1 LivaNova Corporate Summary
7.9.2 LivaNova Business Overview
7.9.3 LivaNova Implantable Cardiovascular Devices Major Product Offerings
7.9.4 LivaNova Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.9.5 LivaNova Key News
7.10 Shree Pacetronix
7.10.1 Shree Pacetronix Corporate Summary
7.10.2 Shree Pacetronix Business Overview
7.10.3 Shree Pacetronix Implantable Cardiovascular Devices Major Product Offerings
7.10.4 Shree Pacetronix Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.10.5 Shree Pacetronix Key News
7.11 Jarvik Heart
7.11.1 Jarvik Heart Corporate Summary
7.11.2 Jarvik Heart Implantable Cardiovascular Devices Business Overview
7.11.3 Jarvik Heart Implantable Cardiovascular Devices Major Product Offerings
7.11.4 Jarvik Heart Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.11.5 Jarvik Heart Key News
7.12 EBR Systems
7.12.1 EBR Systems Corporate Summary
7.12.2 EBR Systems Implantable Cardiovascular Devices Business Overview
7.12.3 EBR Systems Implantable Cardiovascular Devices Major Product Offerings
7.12.4 EBR Systems Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.12.5 EBR Systems Key News
7.13 Medico SpA
7.13.1 Medico SpA Corporate Summary
7.13.2 Medico SpA Implantable Cardiovascular Devices Business Overview
7.13.3 Medico SpA Implantable Cardiovascular Devices Major Product Offerings
7.13.4 Medico SpA Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.13.5 Medico SpA Key News
8 Global Implantable Cardiovascular Devices Production Capacity, Analysis
8.1 Global Implantable Cardiovascular Devices Production Capacity, 2017-2028
8.2 Implantable Cardiovascular Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Cardiovascular Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Cardiovascular Devices Supply Chain Analysis
10.1 Implantable Cardiovascular Devices Industry Value Chain
10.2 Implantable Cardiovascular Devices Upstream Market
10.3 Implantable Cardiovascular Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Cardiovascular Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Implantable Cardiovascular Devices Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|